The largest database of trusted experimental protocols

Su dhl2

Manufactured by Thermo Fisher Scientific

The SU-DHL2 is a laboratory equipment designed for sample preparation and handling. It provides basic functions for sample processing, such as mixing, agitation, and incubation. The device features a compact and durable construction to support standard laboratory workflows.

Automatically generated - may contain errors

2 protocols using su dhl2

1

TCL and BCL Cell Line Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
H9, HH, C5MJ, J. Cam 1.6, SUP-T1, Tib152, and CCL119 are TCL cell lines purchased from the ATCC. SU-DHL6, SU-DHL2, Jeko-1, JVM-2, Z-138, Rec-1 are characterized BCL lines purchased from the ATCC. DND41 is a T-cell line purchased from Deutsche Sammlung von Mikroorganism und Zellkulturen GmbH (DSMZ; Braunschweig, Germany). OCI-LY10 and OCI-LY7 are BCL cell lines from DSMZ. All cell lines were grown in RPMI-1640 (H9, HH, J. Cam 1.6, SUP-T1, Tib-152, CCL119, DND41, Jeko-1, JVM-2, Z-138, Rec-1, SU-DHL6, and SU-DHL2) or IMDM media (C5MJ, OCI-LY10, and OCI-LY7) with 10% FBS (Life Technology) and maintained at a concentration of 0.3 × 106 cells/mL. All cell lines were authenticated from a hematopathologist, including verification of morphology and immunophenotype (11 (link)–13 (link)).
+ Open protocol
+ Expand
2

Culturing and Sourcing Multiple Myeloma Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell lines L363, OPM-2, MM1.S, RPMI-8226, and SU-DHL-2 were cultured in RPMI 1640 GlutaMAX HEPES culture medium (Life Technologies) supplemented with 10% fetal bovine serum (FBS, Biowest) and 100 µg/ml penicillin–streptomycin (Gibco/Life Technologies). UM9 was cultured with 20% FBS, and NCI-H929 with 20% FBS, 1 mM sodium pyruvate (Thermo Fisher), and 50 µM β-mercaptoethanol (Life Technologies). OCI-Ly1, OCI-Ly3, OCI-Ly7, and OCI-Ly10 were cultured in Iscove’s modified Dulbecco’s medium (Life Technologies) supplemented with 20% FBS and 100 µg/ml penicillin–streptomycin. Cell lines L363, RPMI-8226, OPM-2, OCI-Ly3, OCI-Ly7, OCI-Ly1 and NCI-H929 were purchased from DSMZ, MM1.S, OCI-Ly10, and SU-DHL-2 were purchased from ATCC. Cell line UM9 was derived from an MM patient at our UMCU hospital). All cell lines were tested negative for mycoplasma before and during the experiments. Primary MM cell samples were derived from patients diagnosed at the Academic Medical Center, Amsterdam, The Netherlands. This study was conducted and approved by the AMC Medical Committee on Human Experimentation. Informed consent was obtained in accordance with the Declaration of Helsinki.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!